- Details
- Description
Packaging Size:
40 tablets
Composition:
Asciminib Hydrochloride INN
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
Ascentib
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Ascentib (Asciminib Hydrochloride INN) is an oral targeted anti-cancer medicine containing asciminib, a STAMP inhibitor that specifically targets the ABL myristoyl pocket of the BCR-ABL1 protein. It is used primarily for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Ascentib is listed as an anti-cancer medicine with a 40-tablet pack size
